Displaying items by tag: division of hematology and oncology

The new UAB Integrative Medicine Clinic will provide conventional medical care with complementary approaches to tackle the biological, social and spiritual aspects of health and illness.
A key Leukemia & Lymphoma Society grant will provide an opportunity for a UAB researcher to develop a new immunotherapy treatment approach for the leukemia most prevalent in Western countries.
A significant new UAB study published in Cancer shows that key socioeconomic factors, not race, affect survival of younger multiple myeloma patients.
UAB now offers the largest cancer precision medicine clinical trial, NCI-MATCH, with customized treatments for patients based on genetics.
Measure of Mpl gene expression reveals a heterogonous population of leukemia stem cells: one group leukemic and the other group non-leukemic.
Karim Budhwani, a materials science and engineering (MSE) and biomedical engineering (BME) graduate student, presented to the Alabama Commission for Higher Education (ACHE) on December 4, 2015 in Montgomery, Ala.
Page 3 of 5